Analogic is on track with layoffs and facilities closures announced last year, but ALOG shares dive after the company reports disappointing earnings for its 2nd quarter and projects flat progress for the year ahead.
CareFusion's bottom line drops by 10% but hits the mark for analysts, who cast a cautiously optimistic eye on the year ahead.
Analysts are taking a cautious approach to CareFusion (NYSE:CFN) amid increasing costs and a 10% drip in profits for the company's 2nd quarter.
Annual losses at Biomet increase dramatically in a revised earnings release for the Warsaw, Ind.-based orthopedics maker.
Biomet amended its Q4 and annual earnings report to reflect a swing to red in Q4 and much deeper losses for the full year compared to earlier reports.
The Warsaw, Ind.-based orthopedics company posted losses of $221.2 million on $784 million in sales during the 3-month period ended May 31, 2013. An initial earnings report released in July had reported a $20.5 million profit for the quarter.
Tengion posts greater losses during the 2nd quarter as it develops its human organ transplant technology, but rakes in more than $30M in investments.
Tengion (NSDQ:TNGN) almost tripled its losses in the 2nd quarter, but raked in more than $30 million in investments for its human organ regeneration technology.
Medtronic shares come under pressure as investors react to mixed fiscal 1st-quarter results, with earnings in line with expectations but sales missing their target.
Investors pushed shares of Medtronic (NYSE:MDT) down this morning after the world's largest pure-play medical device company reported mixed results for its fiscal 1st quarter.
Fridley, Minn.-based Medtronic posted profits of $953 million, or 93¢ per share, on sales of $4.08 billion for the 3 months ended July 26. That's a 10.3% top-line gain on 1.9% sales growth.
Operating rofits rose 13% during the 2nd quarter for wound management company Kinetic Concepts Inc., despite a nearly 4% sales decline.
Operating profits rose 13.1% during the 2nd quarter for Kinetic Concepts Inc., despite a nearly 4% sales decline for the wound management company.
San Antonio, Texas-based KCI reported operating profits of $110.8 million on sales of $317.8 million for the 3 months ended June 30, according to a regulatory filing.
Syneron Medical's 2nd-quarter earnings meet Wall Street's expectations, but sales fall short, sending shares down on The Street.
Syneron Medical Ltd. (NSDQ:ELOS) stumbled during the 2nd quarter, posting earnings that were even with Wall Street's forecast but just missing sales expectations, sending share prices down this week.